T-Cell Monitoring
Tetramer Assay for Measuring T-Cell Responses
Antigen Panels for Monitoring Cellular Immune Response
The Amplimetrix Tetramer Assay measures T-cell activation to tumor antigens. Using patented tetramer technologies, this assay measures a patient’s cellular immune response to specific panels of tumor antigens, and can reveal the relationship between T-cell activation and clinical outcome to immunotherapy (1,2).
Tetramer Assay components:
The Amplimetrix Tetramer Assay includes study design, tetramer assay, and results with comprehensive analysis and interpretation. Disease-specific panels include:
- Breast cancer
- Colorectal cancer
- Glioblastoma
- Melanoma
- Non-small cell lung cancer
- Pancreatic cancer
- Prostate cancer
- Renal cell carcinoma
- Ovarian cancer
For most disease panels it is possible to measure not only CD8+ cytotoxic T-cell responses but also CD4+ helper T-cells. In addition, the range of patient haplotypes that can be measured is increasing, with almost complete patient coverage for the leading cancer types.
Contact us today to learn how Amplimetrix can improve your results.
For more information, please complete this form. You will be contacted as soon as possible.
Please fill in all required fields.